Clinical Trials
- Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Cognitive Training Study in Parkinson’s Disease
- Mental Health & Behavioral Research, Alzheimer's
Ketamine for the Treatment of Depression in Parkinson's Disease
- Ages40 years - 70 years
- GenderBoth
- Liver, Vision/Eye, Brain, Spinal Cord & Nervous System
Wilson Disease Registry
- GenderBoth